AMY YOUMAN: Open Payments
NPI 1811495153 · DAYTONA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,546 in 146 payments from 45 companies in 2025. Trend: 2023 $2,442 · 2024 $3,316 · 2025 $3,546
Food & beverage: $3,261Education: $285
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 7 | $282 |
| Daiichi Sankyo Inc. | 12 | $245 |
| Janssen Biotech, Inc. | 12 | $230 |
| Merck Sharp & Dohme LLC | 8 | $186 |
| Regeneron Healthcare Solutions, Inc. | 7 | $171 |
| Novartis Pharmaceuticals Corporation | 6 | $148 |
| Incyte Corporation | 4 | $144 |
| AstraZeneca Pharmaceuticals LP | 6 | $143 |
| TerSera Therapeutics LLC | 4 | $126 |
| Genentech USA, Inc. | 6 | $119 |
Products named: Enhertu, KEYTRUDA, LIBTAYO, Zoladex, Trodelvy, BRUKINSA, Orserdu, KISQALI.
Industry payments across FL — which companies pay providers there.
